使用1-T开放式高场强扫描仪对肝顶肝细胞癌进行MRI引导冷冻消融
前瞻性评估1-T开放式MRI引导经皮冷冻消融肝顶肝细胞癌的可行性、安全性和有效性。37例患者37个病灶均手术成功,技术成功率100%,中位随访21.0个月;6个月和1年局部肿瘤进展率分别为2.7%和5.4%,总生存率分别为100%和97.3%;2例需胸腔引流,无其他严重并发症。结论认为该方法可行、安全、有效。
要点
- 肝顶肝细胞癌可行1-T开放式MRI引导经皮冷冻消融,技术成功率100%。
- 6个月和1年局部肿瘤进展率分别为2.7%和5.4%,总生存率分别为100%和97.3%。
- 术后需胸腔引流的胸腔积液2例,无其他严重并发症。
核心结论
- 1-T开放式MRI引导下肝顶肝细胞癌冷冻消融是一种可行、安全、有效的治疗方法。
研究设计与样本
- 前瞻性研究,纳入37例患者37个肝顶肝细胞癌病灶,病灶大小8-38 mm,采用1-T开放式MRI引导经皮冷冻消融,术中使用MR透视自由hand技术,术后随访至少12个月或至死亡。
诊断标准与关键数值
- 技术成功率为100%(37/37)。
- 局部肿瘤进展率6个月为2.7%(1/37),1年为5.4%(2/37)。
- 总生存率6个月为100%(37/37),1年为97.3%(36/37)。
- 中位随访时间21.0个月(范围10-26个月)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The objective of our study was to prospectively evaluate the feasibility, safety, and effectiveness of 1-T open MRI-guided percutaneous cryoablation of hepatic dome hepatocellular carcinomas (HCCs). SUBJECTS AND METHODS. Thirty-seven patients with 37 hepatic dome HCCs underwent MRI-guided percutaneous cryoablations. MR fluoroscopy with a freehand technique was applied in the procedure. All lesions ranged in size from 8 to 38 mm. Patients were followed for at least 12 months after cryoablation or until death. Survival period, local tumor control, and complications were recorded. RESULTS. MRI-guided percutaneous cryoablation procedures were successfully performed on all 37 lesions. The technical success rate was 100%. The median follow-up time was 21.0 months (range, 10-26 months). Two patients with local tumor progression at the 4th and 11th month after the procedure were treated with a supplementary cryoablation. One patient died of upper gastrointestinal hemorrhage at the 10th month after cryoablation. Local tumor progression and overall survival rates were 2.7% (1/37) and 100% (37/37) at 6 months and 5.4% (2/37) and 97.3% (36/37) at 1 year, respectively. Postoperative hydrothorax that required chest tube drainage occurred in two patients; no other severe complications occurred. CONCLUSION. Cryoablation of hepatic dome HCCs with 1-T open MRI guidance is a feasible, safe, and effective therapy method.
引用
- Wang L, Liu C, Liu J, et al. MRI-Guided Cryoablation of Hepatic Dome Hepatocellular Carcinomas Using 1-T Open High-Field-Strength Scanner. AJR Am J Roentgenol. 2019. PMID: 30860902. doi:10.2214/AJR.18.19815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。